Combination antiretroviral therapy and indoleamine 2,3-dioxygenase in HIV infections: Challenges and new opportunities

AIDS

Volumn 30, Issue 11, 2016, Pages 1839-1841

  Ahmad, Ali ^a,b,c   Mehraj, Vikram ^d   Jenabian, Mohammad Ali ^e   Samarani, Suzanne ^a,b,c   Tremblay, Cecile ^a,b,c   Routy, Jean Pierre ^d  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b Infectiology and Immunology ^*  (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

^d MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^e UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

Author keywords

antiretroviral therapy; genome wide association study; HIV; kynurenine; tryptophan

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; INDOLEAMINE 2,3 DIOXYGENASE; INDOLEAMINE 2,3 DIOXYGENASE INHIBITOR; INDOXIMOD; KYNURENINE; TRYPTOPHAN; GAMMA INTERFERON;

ANTIVIRAL THERAPY; DRUG EFFICACY; EDITORIAL; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; SINGLE NUCLEOTIDE POLYMORPHISM; VIRUS IMMUNITY;

HIV INFECTIONS; HUMANS; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INTERFERON-GAMMA;

EID: 84977097732     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000001168     Document Type: Editorial

References (25)

1. Lee SA, Mefford JA, Huang Y, Witte JS, Martin JN, Haas DW, et al. Host genetic predictors of the kynurenine pathway of tryptophan catabolism among treated HIV-infected Ugandans. AIDS 2016; 30:1807-1815.
2. Soliman H, Mediavilla-Varela M, Antonia S. Indoleamine 2, 3-dioxygenase: is it an immune suppressor? Cancer J 2010; 16:354-359.
3. Ball HJ, Jusof FF, Bakmiwewa SM, Hunt NH, Yuasa HJ. Tryptophan-catabolizing enzymes: party of three. Front Immunol 2014; 5:485.
4. Mehraj V, Routy JP. Tryptophan catabolism in chronic viral infections: handling uninvited guests. Int J Tryptophan Res 2015; 8:41-48.
5. Munn DH, Mellor AL. IDO in the tumor microenvironment: inflammation, counter-regulation, and tolerance. Trends Immunol 2016; 37:193-207.
6. Lovelace MD, Varney B, Sundaram G, Lennon MJ, Lim CK, Jacobs K, et al. Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases. Neuropharmacology 2016S0028-3908(16)30096-X. doi: 10. 1016/j. neuropharm. 2016. 03. 024.
7. Palego L, Betti L, Rossi A, Giannaccini G. Tryptophan biochemistry: structural, nutritional, metabolic, and medical aspects in humans. J Amino Acids 2016; 2016:8952520.
8. Munn DH, Sharma MD, Baban B, Harding HP, Zhang Y, Ron D, et al. GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2, 3-dioxygenase. Immunity 2005; 22:633-642.
9. Fougeray S, Mami I, Bertho G, Beaune P, Thervet E, Pallet N. Tryptophan depletion and the kinase GCN2 mediate IFN-ginduced autophagy. J Immunol 2012; 189:2954-2964.
10. Pallotta MT, Orabona C, Bianchi R, Vacca C, Fallarino F, Belladonna ML, et al. Forced IDO1 expression in dendritic cells restores immunoregulatory signaling in autoimmune diabetes. J Cell Mol Med 2014; 18:2082-2091.
11. Nguyen NT, Nakahama T, Le DH, Van Son L, Chu HH, Kishimoto T. Aryl hydrocarbon receptor and kynurenine: recent advances in autoimmune disease research. Front Immunol 2014; 5:551.
12. Kincses ZT, Toldi J, Vécsei L. Kynurenines, neurodegeneration and Alzheimer's disease. J Cell Mol Med 2010; 14:2045-2054.
13. Dell'Osso L, Carmassi C, Mucci F, Marazziti D. Depression, serotonin and tryptophan. Curr Pharm Des 2016; 22:949-954.
14. Planès R, Bahraoui E. HIV-1 Tat protein induces the production of IDO in human monocyte derived-dendritic cells through a direct mechanism: effect on T cells proliferation. PLoS One 2013; 8:e74551.
15. Samikkannu T, Rao KV, Gandhi N, Saxena SK, Nair MP. Human immunodeficiency virus type 1 clade B and C Tat differentially induce indoleamine 2, 3-dioxygenase and serotonin in immature dendritic cells: implications for neuroAIDS. J Neurovirol 2010; 16:255-263.
16. Vyboh K, Jenabian MA, Mehraj V, Routy JP. HIV and the gut microbiota, partners in crime: breaking the vicious cycle to unearth new therapeutic targets. J Immunol Res 2015; 2015:614127.
17. Jenabian MA, Patel M, Kema I, Kanagaratham C, Radzioch D, Thébault P, et al. Distinct tryptophan catabolism and Th17/ Treg balance in HIV progressors and elite controllers. PLoS One 2013; 8:e78146.
18. Page EE, Greathead L, Metcalf R, Clark SA, Hart M, Fuchs D, et al. Loss of Th22 cells is associated with increased immune activation and IDO-1 activity in HIV-1 infection. J Acquir Immune Defic Syndr 2014; 67:227-235.
19. Bipath P, Levay PF, Viljoen M. The kynurenine pathway activities in a sub-Saharan HIV/AIDS population. BMC Infect Dis 2015; 15:346.
20. Tincati C, Douek DC, Marchetti G. Gut barrier structure, mucosal immunity and intestinal microbiota in the pathogenesis and treatment of HIV infection. AIDS Res Ther 2016; 13:19.
21. Jenabian MA, El-Far M, Vyboh K, Kema I, Costiniuk CT, Thomas R, et al. Immunosuppressive tryptophan catabolism and gut mucosal dysfunction following early HIV infection. J Infect Dis 2015; 212:355-366.
22. Chen J, Shao J, Cai R, Shen Y, Zhang R, Liu L, et al. Antiretroviral therapy decreases but does not normalize indoleamine 2, 3-dioxygenase activity in HIV-infected patients. PLoS One 2014; 9:e100446.
23. Dunham RM, Gordon SN, Vaccari M, Piatak M, Huang Y, Deeks SG, et al. Preclinical evaluation of HIV eradication strategies in the simian immunodeficiency virus-infected rhesus macaque: a pilot study testing inhibition of indoleamine 2, 3-dioxygenase. AIDS Res Hum Retroviruses 2013; 29:207-214.
24. Vaccari M, Boasso A, Fenizia C, Fuchs D, Hryniewicz A, Morgan T, et al. Fatal pancreatitis in simian immunodeficiency virus SIV(mac251)-infected macaques treated with 2', 3'-dideoxyinosine and stavudine following cytotoxic-T-lymphocyte-associated antigen 4 and indoleamine 2, 3-dioxygenase blockade. J Virol 2012; 86:108-113.
25. Vacchelli E, Aranda F, Eggermont A, Sautès-Fridman C, Tartour E, Kennedy EP, et al. Trial watch: IDO inhibitors in cancer therapy. Oncoimmunology 2014; 3:e957994.